Results 71 to 80 of about 471,172 (312)

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Investigating the organisational factors associated with variation in clinical productivity in community pharmacies: a mixed-methods study

open access: yesHealth Services and Delivery Research, 2017
Background: Community pharmacies play a key role in health-care systems, dispensing prescriptions and providing medicine-related services. Service provision varies across community pharmacy organisations and may depend on organisational characteristics ...
Sally Jacobs   +8 more
doaj   +1 more source

Strengthening the Free Healthcare Initiative through a pharmacy and supply chain intervention: Partners in Health's experience in rural Sierra Leone

open access: yesThe Lancet Global Health, 2017
Background: To improve high maternal and under-5 mortality—among the worst globally—Sierra Leone's Ministry of Health and Sanitation (MOHS) enacted the Free Healthcare Initiative in 2010.
Sheriff L Bangura, BPharm   +7 more
doaj   +1 more source

Study protocol: The Adherence and Intensification of Medications (AIM) study - a cluster randomized controlled effectiveness study [PDF]

open access: yes, 2010
Background Many patients with diabetes have poor blood pressure (BP) control. Pharmacological therapy is the cornerstone of effective BP treatment, yet there are high rates both of poor medication adherence and failure to intensify medications ...
Bosworth, Hayden B   +8 more
core   +5 more sources

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

open access: yesMolecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix   +13 more
wiley   +1 more source

Origins and history of global and Polish clinical pharmacy

open access: yesFamily Medicine & Primary Care Review
The history of global clinical pharmacy can be traced back to the second half of the 20th century. The initiators of the first efforts to disseminate the practice of clinical pharmacists were American pharmacists and American research centers.
Arkadiusz Adamiszak, Sylwia Adamiszak
doaj   +1 more source

Indole bearing thiadiazole analogs: synthesis, β-glucuronidase inhibition and molecular docking study

open access: yesBMC Chemistry, 2019
Background Indole based thiadiazole derivatives (1–22) have synthesized, characterized by NMR and HREI-MS and evaluated for β-Glucuronidase inhibition. All compounds showed outstanding β-glucuronidase activity with IC50 values ranging between 0.5 ± 0.08 ...
Noor Barak Almandil   +6 more
doaj   +1 more source

Patient safety in health care professional educational curricula: examining the learning experience [PDF]

open access: yes, 2009
This study has investigated the formal and informal ways pre-registration students from four healthcare professions learn about patient safety in order to become safe practitioners.
Dawson, Pam   +2 more
core  

Integration of HIV Care with Primary Health Care Services: Effect on Patient Satisfaction and Stigma in Rural Kenya. [PDF]

open access: yes, 2013
HIV departments within Kenyan health facilities are usually better staffed and equipped than departments offering non-HIV services. Integration of HIV services into primary care may address this issue of skewed resource allocation. Between 2008 and 2010,
Adero, Walter   +8 more
core   +2 more sources

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy